These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions. Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427 [TBL] [Abstract][Full Text] [Related]
3. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering. Chatterton JE; Schlapfer P; Bütler E; Gutierrez MM; Puppione DL; Pullinger CR; Kane JP; Curtiss LK; Schumaker VN Biochemistry; 1995 Jul; 34(29):9571-80. PubMed ID: 7626627 [TBL] [Abstract][Full Text] [Related]
4. Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. Chatterton JE; Phillips ML; Curtiss LK; Milne R; Fruchart JC; Schumaker VN J Lipid Res; 1995 Sep; 36(9):2027-37. PubMed ID: 8558090 [TBL] [Abstract][Full Text] [Related]
5. Immunoenzyme assessment of human apoB-lipoprotein binding to immobilized receptor of low density lipoproteins. 1. Preparation of anti-receptor monoclonal antibodies. Tsibulsky VP; Yakushkin VV; Tikhomirov OYu ; Preobrazhensky SN Biochemistry (Mosc); 1997 Jun; 62(6):596-602. PubMed ID: 9284539 [TBL] [Abstract][Full Text] [Related]
6. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins. Viens L; Lagrost L J Lipid Res; 1997 Jun; 38(6):1129-38. PubMed ID: 9215541 [TBL] [Abstract][Full Text] [Related]
7. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for thermal stability of human low-density lipoprotein. Jayaraman S; Gantz D; Gursky O Biochemistry; 2005 Mar; 44(10):3965-71. PubMed ID: 15751972 [TBL] [Abstract][Full Text] [Related]
10. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853 [TBL] [Abstract][Full Text] [Related]
11. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins. Benvenga S; Cahnmann HJ; Robbins J Endocrinology; 1990 Nov; 127(5):2241-6. PubMed ID: 2226312 [TBL] [Abstract][Full Text] [Related]
12. Platelet activation by the apoB/E receptor-binding domain of LDL. Relou AM; Gorter G; van Rijn HJ; Akkerman JW Thromb Haemost; 2002 May; 87(5):880-7. PubMed ID: 12038793 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Radulescu L; Stancu C; Antohe F Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494 [TBL] [Abstract][Full Text] [Related]
14. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. Young SG; Koduri RK; Austin RK; Bonnet DJ; Smith RS; Curtiss LK J Lipid Res; 1994 Mar; 35(3):399-407. PubMed ID: 7516960 [TBL] [Abstract][Full Text] [Related]
15. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects. Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662 [TBL] [Abstract][Full Text] [Related]
16. Thrombin cleavage of apolipoprotein Bh of rabbit LDL: structural comparisons with human apolipoprotein B-100. Leroy A; Castro G; Agnani G; Saïle R; Barkia A; Fruchart JC J Lipid Res; 1992 Jun; 33(6):889-98. PubMed ID: 1380972 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281 [TBL] [Abstract][Full Text] [Related]
18. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease. Bakalova RA; Hadzhimitova V; Ribarov S Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142 [TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304 [TBL] [Abstract][Full Text] [Related]
20. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype. Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]